SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-008716
Filing Date
2022-12-30
Accepted
2022-12-30 17:00:21
Documents
13
Period of Report
2022-12-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm   iXBRL 8-K 30759
2 NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM sonoma_ex1001.htm EX-10.1 20093
  Complete submission text file 0001683168-22-008716.txt   224711

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE snoa-20221229.xsd EX-101.SCH 3239
4 XBRL LABEL FILE snoa-20221229_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE snoa-20221229_pre.xml EX-101.PRE 22367
7 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3587
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 221502480
SIC: 2834 Pharmaceutical Preparations